Table 2. Consultations, drug reimbursements and absenteeism from work due to the Chikungunya epidemic, La Réunion, 2005–2006.

Parameter	Proportion of excess* [range]	Quantification of excesses (in thousands) [range]
Consultations (services)	25% [16–35%]	470 [195–765]
Drugs reimbursements (cost in Euros)
Antimalarials	59% [54–64%]	36.2 [12.7–61.1]
Analgesics	44% [16–71%]	4027 [2467.1–4720.2]
Proton pump inhibitors	30% [9–50%]	876.5 [432.9–1187.2]
Anxiolytics	24% [0–52%]	43.4 [15–78.5]
Sick leave
Number of people concerned	137% [0–275%]	12.8 [10.7–13.6]
Number of days reimbursed	53% [15–92%]	112.4 [62.4–112.4]

*Compared to consumption outside the epidemic, calculated by a periodic regression model.